Cargando…
The Gamma Gap and All-Cause Mortality
BACKGROUND: The difference between total serum protein and albumin, i.e. the gamma gap, is a frequently used clinical screening measure for both latent infection and malignancy. However, there are no studies defining a positive gamma gap. Further, whether it is an independent risk factor of mortalit...
Autores principales: | Juraschek, Stephen P., Moliterno, Alison R., Checkley, William, Miller, Edgar R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668045/ https://www.ncbi.nlm.nih.gov/pubmed/26629820 http://dx.doi.org/10.1371/journal.pone.0143494 |
Ejemplares similares
-
Gamma gap thresholds and HIV, hepatitis C, and monoclonal gammopathy
por: Liu, Gigi Y., et al.
Publicado: (2020) -
The Gamma Gap Predicts All-Cause Mortality in Chronic Dialysis Patients
por: Avramovski, Petar J., et al.
Publicado: (2021) -
The gamma gap predicts 4-year all-cause mortality among nonagenarians and centenarians
por: Yang, Ming, et al.
Publicado: (2018) -
The association of clinical indication for exercise stress testing with all-cause mortality: the FIT Project
por: Kim, Joonseok, et al.
Publicado: (2016) -
NT‐proBNP and All‐Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study
por: Echouffo‐Tcheugui, Justin B., et al.
Publicado: (2023)